Teva reclaims its spot as top generic drug maker

July 25 2005

Israel-based Teva Pharmaceutical Industries entered an agreement to buy U.S.-based Ivax Corp. today for $7.4 billion in cash and stock ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.